City
Epaper

Russia's single-dose Sputnik Light COVID-19 vaccine approved for use in Mauritius

By ANI | Published: June 02, 2021 2:59 PM

The Russian Direct Investment Fund (RDIF) on Wednesday announced the approval of the Russian single-dose Sputnik Light COVID-19 vaccine by the Mauritius Health Ministry.

Open in App

The Russian Direct Investment Fund (RDIF) on Wednesday announced the approval of the Russian single-dose Sputnik Light COVID-19 vaccine by the Mauritius Health Ministry.

According to a statement by the RDIF, Sputnik Light is the first component of the Sputnik V vaccine. Sputnik Light has demonstrated 79.4 per cent efficacy according to analyzed data taken from 28 days after the injection was administered.

The data was obtained from Russians vaccinated with a single injection, having not received the second one for any reason during the mass vaccination program between December 5, 2020 and April 15 this year.

Mauritius had approved the use of Sputnik V vaccine for emergency use authorisation in March.

"Authorization of Sputnik Light will add a safe and effective COVID vaccine to Mauritius's national portfolio. The vaccine is created on a proven adenoviral vectors platform and enables vaccination of large populations groups more quickly thus creating a herd immunity in a short period," said Kirill Dmitriev, RDIF CEO.

Earlier, Sputnik Light vaccine was also approved for use in the Palestinian territories, according to RDIF.

In a statement on Monday, the RDIF announced the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health of the State of Palestine.

The Sputnik Light vaccine has received authorization for use in Russia, according to the Russian Ministry of Health, the Gamaleya National Research Center of Epidemiology and Microbiology and the RDIF.

On February 21, the Gamaleya Center and RDIF launched a global efficacy study of Sputnik Light. The Phase III clinical study involving 7,000 people was conducted in multiple countries including Russia, the UAE and Ghana.

The RDIF said the Sputnik Light vaccine is based on a well-studied human adenoviral vector platform that has proven to be safe and effective. As of May 5, more than 20 million people globally have received the first injection of the Sputnik V vaccine, containing the first component.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Mauritius health ministryRdifKirill dmitriev
Open in App

Related Stories

InternationalUS announces additional measures against Russian financial system

InternationalSputnik Light's approval in India major step in bilateral cooperation against COVID: RDIF CEO

HealthSputnik V shows strong protection against Omicron: Joint Italian-Russian study

InternationalTalks on production of Sputnik Light COVID vaccine in India nearing completion: Russian Foreign Minister Lavrov

HealthRDIF seeks Sputnik M vaccine registration for adolescents in India

International Realted Stories

InternationalChina to gift new giant pandas to Australia in sign of diplomatic thaw

InternationalRussian security forces kill prisoners to rescue employers taken hostage

InternationalNegotiations underway on sale of surplus renewable energy to India: Lankan President

InternationalMongolia: Democratic Party member assassinated amid parliamentary election campaign

InternationalSri Lanka Navy seizes 702 kg of Tendu leaves